We are delighted to announce that we have implemented the CDC assay for the detection of SARS-CoV-2 – the agent causing the Covid-19 outbreak.
“We can now provide researchers and other professionals quantitative assays of SARS-CoV-2 RNA.
We are now also developing assays for antibodies to SARS-CoV-2 to estimate whether blood donors
and other individuals have been exposed to the virus. These should be available in the coming
weeks to support research into community wide immune status”. Commented Michael Burnet,
managing director of Synovo.
Please read our full press releases below: